Progress in Mesoporous Silica Nanoparticles as Drug Delivery Agents for Cancer Treatment by Eleen Dayana Mohamed Isa, Haslina Ahmad, Mohd Basyaruddin Abdul Rahman, Martin R. Gill

“…Cancer treatment and therapy have made significant leaps and bounds in these past decades. …”
Get full text

Combining mTOR Inhibitors and T Cell-Based Immunotherapies in Cancer Treatment by Alexandre el Hage, Olivier Dormond

Get full text

Dostarlimab as a Miracle Drug: Rising Hope against Cancer Treatment by Vanshikha Singh, Afsana Sheikh, Mohammed A. S. Abourehab, Prashant Kesharwani

“…Immunotherapy is one of the four pillars of cancer treatment that has recently emerged as a beacon of hope for cancer patients. …”
Get full text

Advancing cancer treatment: in vivo delivery of therapeutic small noncoding RNAs by Xiaoyue Yang, Ying Liang, Sheng Tong

“…Furthermore, we shed light on the pivotal challenges hindering the successful translation of these promising therapies into clinical practice, with a specific focus on delivery methods, aiming to stimulate innovative approaches to address this foundational aspect of cancer treatment.…”
Get full text

Compound kushen injection in cancer treatments: Efficacy, active ingredients, and mechanisms by Yang Yang, Yu Lu, Tianduo Pei, Bao Guo, Jingquan Li, Hui Wang, Qian Ba

“…Cancer remains a major cause of death and a severe threat to improve life span around the world. Although the cancer treatments have made great progress, the therapeutic outcomes of malignant tumors are limited due to drug resistance, side effect, and/or immunosuppressive tumor microenvironment. …”
Get full text

Cancer treatment-induced menopause: Meaning for breast and gynecological cancer survivors by Christine S. Davis, Jeanie E. Zinkland, Margaret I. Fitch

“…<p class="p1">Many cancer survivors are faced with irreversible changes resulting from cancer treatment. One such change some women face after cancer is treatment-induced menopause. …”
Get full text

Effective Medicinal Plant in Cancer Treatment, Part 2: Review Study by Wesam Kooti MSC, Karo Servatyari MD, Masoud Behzadifar PhD, Majid Asadi-Samani PhD, Fatemeh Sadeghi MSc, Bijan Nouri PhD, Hadi Zare Marzouni MSc

Get full text

LOCO-REGIONAL RECURRENCE AFTER BREAST CANCER TREATMENT MIMICKING COSTOCHONDRITIS by Jorge Toro-Burguete, Abuzer Dirican, Oya Andacoglu, Atilla Soran

Get full text

Brief Communication: Living with peripheral neuropathy following completion of cancer treatment by Margaret I. Fitch

“…<p class="p1">Recently, a number of large surveys have reported cancer survivors experience physical, emotional, and practical changes following completion of their cancer treatment (Burg et al., 2015; Cancer Control Queensland, 2015; Lerro et al., 2012; Li et al., 2019; Moslassiotis et al., 2017; National Health Services, 2015). …”
Get full text

Gold Derivatives Development as Prospective Anticancer Drugs for Breast Cancer Treatment by Ileana Ielo, Domenico Iacopetta, Carmela Saturnino, Pasquale Longo, Maurilio Galletta, Dario Drommi, Giuseppe Rosace, Maria Stefania Sinicropi, Maria Rosaria Plutino

Subjects: Get full text

Exploration of New Sensitizers for Photodynamic Therapy Targeting Deep Cancer Treatment by Wei Chen

“…The use of novel copper–cysteamine (Cu–Cy) nanoparticles is a good solution for overcoming these issues because Cu–Cy nanoparticles can be effectively activated by X-rays to produce singlet oxygen, which makes it very efficient for deep cancer treatment. Here, I will discuss the use of copper–cysteamine nanoparticles to enhance radiation therapy in combination with PDT and targeting therapies.…”
Get full text

The benefits of propofol on cancer treatment: Decipher its modulation code to immunocytes by Long Gu, Xueqi Pan, Chongcheng Wang, Lei Wang

“…Although anesthetic technology is mature, there is no golden drug selection standard for surgical cancer treatment. To afford the responsibility of human health, a more specific regimen for cancer resection is indeed necessary. …”
Get full text

Combining Immunotherapy and Radiotherapy for Cancer Treatment: Current Challenges and Future Directions by Yifan Wang, Yifan Wang, Weiye Deng, Nan Li, Shinya Neri, Amrish Sharma, Wen Jiang, Steven H. Lin, Steven H. Lin

Subjects: Get full text

Reduction-Hypersensitive Podophyllotoxin Prodrug Self-Assembled Nanoparticles for Cancer Treatment by Xinhui Wang, Yuequan Wang, Jiaxin Yu, Qian Qiu, Rui Liao, Shenwu Zhang, Cong Luo

“…Our work will advance the pace of podophyllotoxin towards clinical cancer treatment.…”
Get full text

Penile Rehabilitation after Prostate Cancer Treatment: Which Is the Right Program? by Roberto Castellucci, Piergustavo De Francesco, Antonio De Palma, Davide Ciavarella, Simone Ferretti, Michele Marchioni, Luigi Schips

Subjects: Get full text

Engineering tumor-oxygenated nanomaterials: advancing photodynamic therapy for cancer treatment by Tingting Zuo, Xiaodie Li, Xuan Ma, Ye Zhang, Xueru Li, Xuehai Fan, Mingze Gao, Donglin Xia, Huijun Cheng, Huijun Cheng

“…Furthermore, we delineate ongoing challenges and propose strategies to improve PDT’s clinical impact in cancer treatment.…”
Get full text

The Potential of Dendritic Cell Subsets in the Development of Personalized Immunotherapy for Cancer Treatment by Anna Valerevna Gorodilova, Kristina Viktorovna Kitaeva, Ivan Yurevich Filin, Yuri Pavlovich Mayasin, Chulpan Bulatovna Kharisova, Shaza S. Issa, Valeriya Vladimirovna Solovyeva, Albert Anatolyevich Rizvanov

Get full text

Sacral insufficiency fracture following rectal cancer treatment – case report by Agnieszka Pikuła, Tomasz Stanisław Pikuła, Mateusz Pastuszak

Get full text

Phytochemicals and Cancer Treatment: Cell-Derived and Biomimetic Vesicles as Promising Carriers by Sara Baldassari, Alice Balboni, Giuliana Drava, Daniela Donghia, Paolo Canepa, Giorgia Ailuno, Gabriele Caviglioli

Get full text

SHORT OVERVIEW OF CLINICAL TRIALS WITH CURRENT IMMUNOTHERAPEUTIC TOOLS FOR CANCER TREATMENT by T. S. Nepomnyashchikh, D. V. Antonets, R. A. Maksyutov

“…Different immunotherapeutic drugs based on recombinant cytokines and monoclonal antibodies are widely used in cancer therapy, and a large number of experimental cancer treatments have been developed, many of which are currently undergoing various stages of clinical trials. …”
Get full text